LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/ulrich medical Offers New Spinal Implant
Spine

ulrich medical Offers New Spinal Implant

March 6, 2013 1 min read Premium comments

Advertisement

ulrich medical Offers New Spinal Implant
flamenco / Courtesy of Ulrich Medical
Secondary

ulrich medical USA, Inc. is releasing a new spinal implant, called the flamenco Thoracolumbar Rod-Screw System, into the U.S. market. The system is designed to enhance decompression and stabilization of the thoracic and lumbosacral spine when used for fusion surgeries.

“This product provides simple, straight-forward instrumentation and maximized tray layout, which helps decrease critical operating room time for the patient and surgical team, ” said Tom Carter, senior marketing manager, ulrich medical USA. “It provides surgeons with a standard 5.5 mm rod and tulip head design similar to the most popular pedicle screw systems currently available in the United States.”

“The release of the flamenco system enhances ulrich’s market leadership position in expandable corpectomy cage technologies, ” said Erika Laskey, company vice president of sales and marketing. “It offers surgeons German-engineered supplemental fixation solutions for use with our five expandable vertebral body replacement (VBR) product lines for complex trauma and tumor applications.”

Heinrich C. Ulrich founded ulrich medical® in Ulm, Germany, in 1912 to develop high quality, precision surgical instruments. The company’s products are used in medical applications ranging from spine surgery to diagnostic imaging. The U.S. division, ulrich medical USA, Inc., is located in St. Louis, Missouri.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy